News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

INFORMS Names Class of 2024 Fellows
News Release

BALTIMORE, MD, September 26, 2024 – From reshaping healthcare delivery to optimizing global supply chains, developing life-saving algorithms and numerous other significant contributions, 12 pioneers in operations research and analytics are set to receive one of the highest honors in the field – being named an INFORMS Fellow. INFORMS, the premier international association for the decision and data sciences, proudly announces its 2024 class of Fellows – leaders whose innovative contributions have transformed industries, improved lives worldwide and significantly advanced INFORMS’ fields of interests. These luminaries will be celebrated at the 2024 INFORMS Annual Meeting, held October 20-23, in Seattle, Washington.

Read More
Presidential election chaos drives early holiday shopping
Media Coverage

Blame the presidential election for extra early Christmas shopping this year.

Read More
Sheldon H. Jacobson: Is artificial intelligence for the birds? More than you may think.
Media Coverage

The test for any breakthrough technology is often where you least expect it, but once it “conquers” that application, even more possibilities may emerge.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
CEOs Bring in Big Bucks, Even More When a CFO is Hired after Them

CEOs Bring in Big Bucks, Even More When a CFO is Hired after Them

CEOWorld Magazaine, September 9, 2020

It’s common knowledge that chief executive officers (CEOs) of companies are highly paid, but new research shows a certain phenomenon can bump that yearly salary up even higher—about 10% higher. New research in the INFORMS journal Management Science finds CEO compensation climbs if they appoint a chief financial officer (CFO) after them. The increased compensation is mostly concentrated in the early years of the newly hired CFO’s tenure and in components of compensation that vary with hitting analyst-based earnings targets. The work suggests that some finance chiefs might be pressured to tweak earnings to boost the stock price, and as a result, CEO compensation.

The Sensible Way to Return to College During the COVID-19 Pandemic

The Sensible Way to Return to College During the COVID-19 Pandemic

The Washington Times, September 9, 2020

A normal return to college this fall is anything but normal. The variety of COVID-19 impacted education plans range from fully online to fully in-person, and everything in between. Many colleges have cancelled or delayed football and other sports this fall. Colleges have welcomed students back to campus, and students are glad to be back; some have reciprocated with new infections, mostly asymptomatic. College life has been upended, with no end in sight.

 Two COVID Vaccines in Phase 3; CDC Plans Distribution

Two COVID Vaccines in Phase 3; CDC Plans Distribution

The Corvallis Advocate, September 8, 2020

Currently, dozens of experimental COVID-19 vaccines are being developed in the United States and throughout the world, including seven vaccine candidates funded by the U.S. government, according to a report by the Statesman Journal. Two of the seven vaccines are in Phase 3 clinical trials, which now begs the question: how will the vaccine be distributed, and who will be first to receive it when it’s available?

Coronavirus Update: Vaccine Makers Promise Safety, Lingering Effects From Severe Cases

Coronavirus Update: Vaccine Makers Promise Safety, Lingering Effects From Severe Cases

Consumer Affairs, September 8, 2020

Nine of the pharmaceutical companies actively working on a coronavirus (COVID-19) vaccine have pledged to make sure whatever drug they come up with is safe for people, even if it means taking longer to develop. In a joint statement, the U.S. and European firms, including AstraZeneca, Pfizer, and GlaxoSmithKline, promised to “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first Covid-19 vaccines.”

Coronavirus Updates: AstraZeneca Halts Vaccine Trials After 'Unexplained Illness'; Study Links 260K Cases to Sturgis Motorscycle Rally

Coronavirus Updates: AstraZeneca Halts Vaccine Trials After 'Unexplained Illness'; Study Links 260K Cases to Sturgis Motorscycle Rally

USA Today, September 8, 2020

After U.S. health officials warned Americans to continue social distancing and wearing masks on Labor Day weekend, the United States may report its 190,000th death from the new coronavirus on Tuesday or Wednesday. In sports news, the American men are out at the U.S. Open after Frances Tiafoe, who had tested positive for COVID-19 in July, lost Monday to No. 4 Daniil Medvedev of Russia. The next Grand Slam event, the French Open, which begins later this month, will allow spectators, organizers announced Monday.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine